WSC 2023 Clinical Trials

WSC 2023 Clinical Trials

Explore the clinical trials presented in the plenary sessions at the 15th World Stroke Congress for FREE!

Colchicine in Patients With Acute Ischemic Stroke or Transient Ischemic Attack (CHANCE-3)

Prof. Yongjun Wang

Results of the Randomized Controlled Trial To Test Efficacy and Safety of Thrombectomy in Stroke With Extended Lesion and Extended Time Window (TENSION)

Prof. Götz Thomalla

Randomized Trial of Andexanet Alfa Versus Usual Care in Patients With Acute Intracranial Hemorrhage While on an Oral Factor Xa Inhibitor ANNEXa-I

Dr. Stuart Conolly

Tenecteplase versus Alteplase for Acute Stroke within 4.5h of onset the secont Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST-2)

Prof. Keith Mur

A Secondary Analysis of the AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke (ARCADIA) Randomized Trial

Dr. David Tirschwell

Extension of Stroke Care with Adjuvant neuroProtection to Endovascular treatment - Nerinetide EXcluding Thrombolysis

Prof. Michael Hill

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Explore the Efficacy and Safety of Intravenous Nerinetide (NA-1) Initiated by Paramedics in the Field for Suspected Stroke Within Three Hours of Symptoms Onset

Prof. Dr. James Christenson

Polypill and Riskometer to prevent stroke and cognitive impairment in primary health care - PROMOTE study

Prof. Sheila Martins
LinkedIn Twitter Youtube